Cell-free DNA in Transplant Assessments
Cell-free DNA (cfDNA) is the term used to describe the small fragments of DNA that occur naturally and circulate in the blood stream. Advanced technology using cfDNA has improved testing and screening options for transplant recipients. Donor-derived cell-free DNA (dd-cfDNA) can assess the amount of cell-free DNA in an organ recipient’s blood that originates from the donor. Elevated levels of cfDNA in the recipient’s blood may signify an increase in cell death from kidney injury and/or rejection. Studies have shown that cfDNA testing is more sensitive and specific than serum creatinine and is able to detect acute rejection at an earlier stage. Join us to hear from genetic testing experts as they discuss cell-free DNA and its potential as a powerful biomarker in transplant assessments.
Presented on January 28, 2020 by Phil Gauthier, MD and Alexander Wiseman, MD.
Видео Cell-free DNA in Transplant Assessments канала Organ Donation and Transplantation Alliance
Presented on January 28, 2020 by Phil Gauthier, MD and Alexander Wiseman, MD.
Видео Cell-free DNA in Transplant Assessments канала Organ Donation and Transplantation Alliance
Показать
Комментарии отсутствуют
Информация о видео
29 января 2021 г. 2:23:39
00:52:14
Другие видео канала
"Dude, Where's My Liver?" Is Cannabis a Barrier to Liver Transplantation?End-of-Life Conversations: A Collaborative Approach to DonationOvercoming the Challenge of Timely Declaration of Brain DeathDCDD Heart Recovery: Achieving the Impossible Through Innovative Perfusion TechnologiesDonation Champions: Strategies for Developing Advocates Inside & Outside of the HospitalMissed Signals: Navigating a Difficult Phone ConversationHighlights from the OPTN Donation after Circulatory Death Procurement CollaborativeDetermining Eligibility of Blood Type B Candidates for Transplant with Blood Type A 2 KidneysAbstract: Organ Yield of Normothermic Machine Perfusion Procurement of DCD HeartsConfronting Stigma: The Impact of Substance Use on Organ Transplantation WebinarA Comparative Philosophical Perspective on The Ethics of Normothermic Regional PerfusionTransplant C-Suite Webisode: Vol. 2, Issue 1: Transplant Regulatory Oversight and RequirementsInnovations to Improve the Quality of Processes and Outcomes - 2020 National Critical Issues ForumConversation Series: Breaking Barriers for Native Americans Seeking Health Care & Organ TransplantsThe Littlest Donors: Honoring the Gift of Life through Neonatal DonationUtilizing Data to Improve Your Organization's Performance - National Critical Issues Forum 2020The Alliance Conversation Series: Addressing Barriers to Cultural IntelligenceGlenn Matsuki's Transplant JourneyThe Alliance Conversation Series - Strategies to Increase Organ UtilizationThe Alliance Conversation Series:Combatting the Stress Endured by First Responders of Organ DonationWhy Does Social Support Matter For Transplant?